Personal information

Activities

Employment (5)

Philipps-Universität Marburg: Marburg, DE

2019 to present | Director (Institute of Pathology)
Employment
Source: Self-asserted source
Carsten Denkert

Charité Universitätsmedizin Berlin: Berlin, Berlin, DE

2009 to 2018 | Full Professor of Pathology (Institute of Pathology)
Employment
Source: Self-asserted source
Carsten Denkert

Charité Universitätsmedizin Berlin: Berlin, Berlin, DE

2004 to 2009 | Consultant in surgical pathology (Institute of Pathology)
Employment
Source: Self-asserted source
Carsten Denkert

Charité Universitätsmedizin Berlin: Berlin, Berlin, DE

1997 to 1997 | Resident in surgical pathology (Institute of Pathology)
Employment
Source: Self-asserted source
Carsten Denkert

Heinrich-Heine-Universitat Düsseldorf: Düsseldorf, Nordrhein-Westfalen, DE

1996 to 1997 | Resident in Internal Medicine (Clinic of Gastroenterology)
Employment
Source: Self-asserted source
Carsten Denkert

Education and qualifications (1)

Medizinische Fakultät der RWTH Aachen: Aachen, Nordrhein-Westfalen, DE

1989 to 1996
Education
Source: Self-asserted source
Carsten Denkert

Funding (6)

TransLUMINAL-B

2015-07 to 2018-06 | Grant
Deutsche Krebshilfe (Bonn, DE)
Source: Self-asserted source
Carsten Denkert

Transcan UGI-1

2014 to 2016 | Grant
Bundesministerium für Bildung und Forschung (Berlin, DE)
Source: Self-asserted source
Carsten Denkert

RESPONSIFY

2012 to 2015 | Grant
Research Executive Agency (Brussels, BE)
Source: Self-asserted source
Carsten Denkert

ARROWS

2009 to 2012 | Grant
Research Executive Agency (Brussels, BE)
Source: Self-asserted source
Carsten Denkert

METAcancer FP7

2008 to 2011 | Grant
Research Executive Agency (Brussels, BE)
Source: Self-asserted source
Carsten Denkert

NEOpredict - BMBF

2007 to 2011 | Grant
Bundesministerium für Bildung und Forschung (Berlin, DE)
Source: Self-asserted source
Carsten Denkert

Peer review (5 reviews for 4 publications/grants)

Review activity for Cancer cell. (1)
Review activity for Die Pathologie (1)
Review activity for Nature communications (1)
Review activity for NPJ breast cancer. (2)